EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico identification, high yielding isolation and in vitro validation of 6β-cinnamoyl-7β -hydroxyvouacapen – 5α - ol as a Wnt/β-catenin pathway targeted anti-cancer secondary metabolite of Caesalpinia pulcherrima

Nirwani N Seneviratne, Tolulope P Saliu, Fathima T Muhinudeen, Sanadie D Gamage, Prabudhi S Garusinghe, Damith Chathuranga, Vinoda D Athukorala, Ashein Kothalawala, Asirini H Jayasekara, Rajitha K Rathnayaka, Umanda Anjalee De Silva, Mohamed Faries und 7 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0334238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Nirwani N Seneviratne und 18 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB), University of Colombo, Colombo, Sri Lanka. Hauptthemen laut MEDLINE: Caesalpinia, Wnt Signaling Pathway, Antineoplastic Agents, Phytogenic, Diterpenes. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation of Sri Lanka.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Wnt/β-catenin signaling pathway is frequently dysregulated in cancer stem cells (CSCs), a sub population of cancer cell mass that drives tumor proliferation, metastasis, recurrence, and chemoresistance. Despite its therapeutic significance, no clinically approved drugs specifically target this pathway. In the present study, secondary metabolites of the medicinal plant Caesalpinia pulcherrima was computationally screened by molecular docking, dynamics simulation and Molecular Mechanics Poisson-Boltzmann Surface Area (MM-PBSA) based free energy calculations to identify potential inhibitors of β-catenin–Tcf/Lef interaction, a key downstream event essential for Wnt/β-catenin signaling. Diterpene metabolite 6β-Cinnamoyl-7β-hydroxyvouacapen-5α-ol (6βCHV) was identified as a potent inhibitor of the pathway along with four previously reported Wnt/β-catenin pathway inhibitors. To validate the results, bioactivity-guided isolation of major active compound was performed using NTERA-2 cells as a cancer stem cell (CSC) model. The isolated compound was spectroscopically characterized and confirmed to be 6βCHV. Anti-proliferative activity assays revealed that 6βCHV suppressed proliferation of breast cancer stem cells (bCSCs) (IC₅₀ = 49.18 µM), NTERA-2 cells (IC₅₀ = 8.92 µM), and highly Wnt-dependent cancer types, including gastric adenocarcinoma (IC₅₀ = 1.90 µM), hepatocellular carcinoma (IC₅₀ = 5.96 µM), and ovarian carcinoma (IC₅₀ = 7.66 µM). 6βCHV upregulated the tumor suppressor gene, p53 while downregulating Wnt target genes, Cyclin D1 and CD44 leading to apoptosis in bCSCs as confirmed by Caspase 3/7 activation. These findings establish 6βCHV as the principal anticancer compound in C. pulcherrima , exerting its effects, at least in part, through Wnt/β-catenin pathway inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaesalpiniaWnt Signaling PathwayAntineoplastic Agents, PhytogenicDiterpenesHumansMolecular Docking SimulationCell Line, Tumorbeta CateninNeoplastic Stem CellsCell ProliferationComputer SimulationMolecular Dynamics Simulation

Substanzen

beta CateninAntineoplastic Agents, PhytogenicDiterpenes

Autor:innen und Institutionen

  • Institute of Biochemistry, Molecular Biology and Biotechnology (IBMBB), University of Colombo, Colombo, Sri Lanka.
  • Central Department of Chemistry, Tribhuvan University, Kirtipur, Kathmandu, Nepal.

ORCID-Profile: Kanishka S Senathilake, Kamani H Tennekoon

Förderung

  • National Science Foundation of Sri Lanka

Zitieren

APA

Seneviratne, N. N., Saliu, T. P., Muhinudeen, F. T., Gamage, S. D., Garusinghe, P. S., Chathuranga, D., Athukorala, V. D., Kothalawala, A., Jayasekara, A. H., Rathnayaka, R. K., De Silva, U. A., Faries, M., Weragoda, T. H., Wijerathne, S. K., Rajagopalan, U., Senathilake, K. S., Tennekoon, K. H., Adhikari, A., & Samarakoon, S. R. (2025). In silico identification, high yielding isolation and in vitro validation of 6β-cinnamoyl-7β -hydroxyvouacapen – 5α - ol as a Wnt/β-catenin pathway targeted anti-cancer secondary metabolite of Caesalpinia pulcherrima. PLOS One. https://doi.org/10.1371/journal.pone.0334238

Vancouver

Seneviratne NN, Saliu TP, Muhinudeen FT, Gamage SD, Garusinghe PS, Chathuranga D, et al. In silico identification, high yielding isolation and in vitro validation of 6β-cinnamoyl-7β -hydroxyvouacapen – 5α - ol as a Wnt/β-catenin pathway targeted anti-cancer secondary metabolite of Caesalpinia pulcherrima. PLOS One. 2025. doi:10.1371/journal.pone.0334238

BibTeX
@article{Seneviratne2025,
  author = {Seneviratne, Nirwani N and Saliu, Tolulope P and Muhinudeen, Fathima T and Gamage, Sanadie D and Garusinghe, Prabudhi S and Chathuranga, Damith and Athukorala, Vinoda D and Kothalawala, Ashein and Jayasekara, Asirini H and Rathnayaka, Rajitha K and De Silva, Umanda Anjalee and Faries, Mohamed and Weragoda, Thimali H and Wijerathne, Shalini K and Rajagopalan, Umapriyatharshini and Senathilake, Kanishka S and Tennekoon, Kamani H and Adhikari, Achyut and Samarakoon, Sameera R},
  title = {In silico identification, high yielding isolation and in vitro validation of 6β-cinnamoyl-7β -hydroxyvouacapen – 5α - ol as a Wnt/β-catenin pathway targeted anti-cancer secondary metabolite of Caesalpinia pulcherrima},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0334238}
}
Kostenlos starten →